Literature DB >> 1357772

Glutathione metabolic enzyme activities in diabetic platelets as a function of glycemic control.

A Muruganandam1, C Drouillard, R J Thibert, R M Cheung, T F Draisey, B Mutus.   

Abstract

Type 1 diabetic subjects categorized on the basis of the glycated haemoglobin content of their blood (low less than 7%; medium, greater than 7% and less than 11%; high, greater than 11%) were analyzed for total intraplatelet GSH as well as for the steady-state kinetic parameters (apparent KM and apparent Vmax) of some glutathione metabolic enzymes including glutathione reductase, glutathione peroxidase, gamma-glutamyltrans-peptidase and glutathione-S-transferase. This study indicates that intraplatelet GSH content of subjects with low glycated-haemoglobin is approximately 2-fold higher than those with medium glycated-haemoglobin. There was no further decrease in intraplatelet-GSH in subjects with high glycated-haemoglobin. The kinetic parameters of the platelet-enzymes studied (glutathione reductase, gamma-glutamyltranspeptidase and glutathione-S-transferase) were essentially independent of the glycation state of the subject. However, the apparent KM of glutathione peroxidase was approximately 4-fold higher in the subjects with high glycated-haemoglobin, in comparison to low subjects. This decrease in affinity could possibly result from the susceptibility of this enzyme to non-enzymatic glucosylation as purified samples of glutathione peroxidase incubated in vitro with glucose showed similar increases in apparent KM. These results are discussed in terms of the potential contribution of glutathione peroxidase impairment, to the hyperaggregability of the diabetic platelet.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357772     DOI: 10.1016/0049-3848(92)90268-f

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Balneotherapy and platelet glutathione metabolism in type II diabetic patients.

Authors:  Y Ohtsuka; N Yabunaka; I Watanabe; H Noro; Y Agishi
Journal:  Int J Biometeorol       Date:  1996-09       Impact factor: 3.787

2.  Balneotherapy in medicine: A review.

Authors:  Ali Nasermoaddeli; Sadanobu Kagamimori
Journal:  Environ Health Prev Med       Date:  2005-07       Impact factor: 3.674

Review 3.  Diabetes, oxidative stress and physical exercise.

Authors:  Mustafa Atalay; David E Laaksonen
Journal:  J Sports Sci Med       Date:  2002-03-04       Impact factor: 2.988

4.  In vitro and in vivo effects of selenium and selenium with vitamin E on platelet functions in diabetic rats relationship to platelet sorbitol and fatty acid distribution.

Authors:  C Douillet; M Bost; M Accominotti; F Borson-Chazot; M Ciavatti
Journal:  Biol Trace Elem Res       Date:  1996-12       Impact factor: 3.738

Review 5.  Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link.

Authors:  D J Korczak; S Pereira; K Koulajian; A Matejcek; A Giacca
Journal:  Diabetologia       Date:  2011-07-26       Impact factor: 10.122

Review 6.  Pathophysiologic role of redox status in blood platelet activation. Influence of docosahexaenoic acid.

Authors:  M Lagarde; C Calzada; E Véricel
Journal:  Lipids       Date:  2003-04       Impact factor: 1.880

7.  Argan oil prevents prothrombotic complications by lowering lipid levels and platelet aggregation, enhancing oxidative status in dyslipidemic patients from the area of Rabat (Morocco).

Authors:  Adil Haimeur; Hafida Messaouri; Lionel Ulmann; Virginie Mimouni; Azelarab Masrar; Abdelmjid Chraibi; Gérard Tremblin; Nadia Meskini
Journal:  Lipids Health Dis       Date:  2013-07-20       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.